慢性丙型肝炎的联合治疗：干扰素与利巴韦林。
Combination therapy for chronic hepatitis C: interferon and ribavirin.
作者信息
Christie J M, Chapman R W
机构信息
Department of Gastroenterology, John Radcliffe Hospital, Oxford.
出版信息
Hosp Med. 1999 May;60(5):357-61. doi: 10.12968/hosp.1999.60.5.1116.
PMID:10396412
Abstract
Hepatitis C virus (HCV) infection is one of the commonest causes of liver cirrhosis and hepatocellular carcinoma. This review deals with treatment of chronic HCV infection with a combination of interferon and ribavirin. Recent trials have shown that approximately 40% of patients will clear HCV with combination treatment. This is an important advance in the treatment of this serious viral infection.
摘要
丙型肝炎病毒（HCV）感染是肝硬化和肝细胞癌最常见的病因之一。本综述探讨了干扰素和利巴韦林联合治疗慢性HCV感染的情况。近期试验表明，联合治疗可使约40%的患者清除HCV。这是这种严重病毒感染治疗方面的一项重要进展。
Zotero 插件